How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

LQDA Jan 2025 12.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5500

-0.1000

(-3.77%)

At close: 09:30AM EDT

Loading interactive chart…

Simply Wall St.
Liquidia Insiders Placed Bullish Bets Worth US$3.00m
Over the last year, a good number of insiders have significantly increased their holdings in Liquidia Corporation...
Investor's Business Daily
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Liquidia stock retook its 50-day line on a U.S. judge's ruling on a patent dispute with United Therapeutics.
GlobeNewswire
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
On May 31, Judge Andrews denied United Therapeutics’ motion for a preliminary injunction to block the launch of YUTREPIA in the PH-ILD indicationRuling reinforces the clear path for FDA to issue final decision on amended NDA for YUTREPIA to treat both PAH and PH-ILD MORRISVILLE, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 31, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the motion for pre